Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 06/18/2013

Company Name Symbol %Change
STAAR SURGIC STAA
10.98%
LUMOS NETWOR LMOS
5.70%
INSTEEL IND IIIN
5.28%
ERICKSON AIR EAC
5.10%
ASSURED GUAR AGO
4.98%

Barclays to Sell BlackRock Stake

by Zacks Equity Research

May 23, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

In an effort to meet the Basel III capital requirements and boost profitability, Barclays PLC (BCS - Snapshot Report) has decided to sell its 19.6% stake (about 35.2 million shares) in BlackRock Inc. (BLK - Analyst Report). The company will dispose approximately 26.2 million shares of BlackRock in an underwritten public offering at a price of $160.00 per share. Additionally, BlackRock would buyback nearly 6.4 million shares for $1.0 billion.

With regard to the public offering, the underwriters – Morgan Stanley (MS - Analyst Report), BofA Merrill Lynch, a unit of Bank of America Corporation (BAC - Analyst Report), and Barclays Capital Inc. – have a 30 days option to purchase extra 2.6 million BlackRock shares from Barclays. If the book-runners fully exercise their options, the company will completely exit from BlackRock.

Barclays will receive net proceeds of about £3.5 billion ($5.5 billion) from the abovementioned stake sell. The net gain from the sale, which will be recognized in the financial statement, would be about £0.2 billion ($0.13 billion). Though the disposal of shares would have no material impact on the company’s net income, it would lead to a 0.05% increase in its core tier 1 ratio.

The Story Behind

Following the divestiture of its ETF and investment fund unit, Barclays Global Investors (BGI) to BlackRock in December 2009, Barclays had received BlackRock shares as a part of sale consideration. BlackRock had paid 37.6 million common and preferred shares along with $6.65 billion in cash to Barclays for buying BGI.

At that time, Barclays was in need of capital due to the financial crisis, and the disposal of BGI provided the much needed stability to its balance sheet. However, in September 2011, the company wrote down its investments in BlackRock to a fair value of £3.4 billion ($5.3 billion).

BlackRock Stake Sale in the Past

In November 2010, Bank of America and PNC Financial Services Group Inc. (PNC - Analyst Report) sold $8.3 billion worth of stock in BlackRock. Of the combined 51.1 million shares sold, Bank of America contributed 43.6 million and PNC the rest. The shares were priced at $163.00 each. A substantial part of this disposal was taken up by Japan-based Mizuho Financial Group Inc. (MFG - Snapshot Report).

Bank of America, which held 34% stake in BlackRock, had obtained this stake as part of its acquisition of Merrill Lynch & Co. in 2009. PNC Financial’s 24% stake dated back before 1999, when BlackRock went public.

Conclusion

Barclays’ decision to sell stake in BlackRock and focus on its core operations is expected to help management meet its ROE target of 13%. For 2011, the company had reported ROE of 6.6% compared with 6.8% in 2010.

Moreover, with this step, Barclays will be able to deploy capital by investing in its franchise, leading to a growth in top line. Also, the stake sale would help the company to mitigate capital constraints, which it would have faced under new regulations.

For BlackRock, the disposal will remove an overhang on the stock and provide it with more financial flexibility. Following the closure of this sale, PNC Financial would remain one of the largest institutional stakeholders in BlackRock with 21% stake.

Currently, Barclays retains a Zacks #2 Rank, which translates into a short-term Buy rating, while BlackRock retains a Zacks #3 Rank, which translates into a short-term Hold rating.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.